LONDON, April 03, 2023--(BUSINESS WIRE)--C3 AI (NYSE: AI), the Enterprise AI application software company, has today announced the relocation of their European, Middle East and Africa (EMEA) headquarters from Paris, France to London, United Kingdom. "Our new EMEA headquarters represents an important next step for C3 AI," said C3 AI CEO Thomas M. Siebel. "As a global company, we are proud to call London our EMEA base and we look forward to the opportunity for even closer collaboration with the UK's world-class technology and artificial intelligence experts, businesses, and institutions." C3 AI has had a presence in Europe since the company's inception in 2009, with offices currently located in London, Paris, Munich, Rome, and Amsterdam. The decision to relocate the central EMEA operation to London ties in with the business's ambitious 2023 targets.

PALO ALTO, Calif., October 13, 2022--(BUSINESS WIRE)--SkyHive, the first company to map and sequence the global labor market in real-time, provide workforce intelligence, and guide the rapid reskilling of workers and communities around the world, today announced it has joined the Responsible Artificial Intelligence Institute (RAII), an independent non-profit organization creating governance standards and certifications for AI systems and scalable solutions for practitioners. "We are pleased to welcome SkyHive into RAII as our newest member," said Ashley Casovan, Executive Director of RAII. "SkyHive uses business as a force for good, so it's only natural that the company has implemented ethical AI principles from day one. It has gained recognition from OECD and the Global Partnership on Artificial Intelligence and has established itself as a clear pioneer of purpose-driven and socially beneficial AI." RAII partners with organizations across public and private sectors, including corporations, NGOs, academic institutions, and government entities, to ensure that adopted and created AI systems are compliant, cost-effective, and built on recognized global best practices. RAII also provides value-add offerings for members, including readiness assessments, policy and governance guidance, regulatory and compliance tracking, and regular convening events and working groups for AI subject matter experts.

WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced it has entered a new collaboration with a large pharmaceutical company to extend the industry's top-rated machine learning models for the prediction of ionization constants (pKa) in the ADMET Predictor platform. In this collaboration, the partner company will contribute tens of thousands of proprietary pKa measurements. The team at Simulations Plus will aim to leverage the expansive databases to improve the accuracy of predictions, and extend the chemical coverage space, using its novel machine learning and atomic descriptor calculation methods. Dr. Robert Fraczkiewicz, Research Fellow and project lead, said: "The ionization of molecules in water impacts nearly all properties driving the absorption, distribution, metabolism, and elimination processes which occur in vivo and determine whether a molecule can be turned into a drug. We identified early the importance of accurately, and rapidly, predicting this information using machine learning approaches and were fortunate to benefit from government grants and other collaborations over the years to develop novel 2D pKa models which have consistently outperformed other software and are on par with the accuracy of the best computationally intensive ab initio methods. This new partnership will enhance our current approaches and further distinguish ADMET Predictor as the preeminent property prediction platform in the drug discovery space. We value the trust and confidence our partner has in the people and technologies at Simulations Plus, and our team is looking forward to working with them to achieve our mutual goals."

Ontrak, Inc. (NASDAQ: OTRK) ("Ontrak Health" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today promoted Judith Feld, MD, to Chief Medical Officer replacing Robert Accordino, MD, who is leaving Ontrak Health to focus on his private practice. Dr. Feld begins immediately in the role and will report to Brandon LaVerne, Co-President and Chief Operating Officer. Dr. Feld joined Ontrak in 2019 as National Medical Director and was promoted to Chief Clinical Strategy Officer earlier this year. She has been instrumental in developing Ontrak Health's new evidence-based clinical model that engages hard to reach members on behalf of health plans through a whole-person approach to care and treatment. Dr. Feld brings over 30 years of experience to the role and is a Distinguished Life Fellow of the American Psychiatric Association, from whom she received the APA's Bruno Lima Award for Disaster Relief for her volunteer work in New Orleans with first responders following Hurricane Katrina.

Veryfi, using artificial intelligence (AI) technology to transform documents into structured data in just seconds, has announced continued strong business momentum and growth in the second quarter. As economic concerns increase, many companies begin to reduce their staff to control costs; 88 percent of job loss in routine occupations occurs within 12 months of a recession. While economic uncertainty continues, Veryfi has emerged as a trusted, reliable partner for companies seeking greater efficiency and stronger customer relationships, continuing its strong annual recurring revenue (ARR) growth. In the second quarter, Veryfi added over a dozen new logos and major accounts including a top supplier of enterprise resource planning software and one of the world's largest CRM/Direct Marketing Network companies. "As companies seek new ways to increase efficiency and manage costs to position themselves for a challenging economy, Veryfi is leading the way, applying AI to automate routine data entry and streamline business processes," said Ernest Semerda, co-founder and CEO of Veryfi.

Today at the Automate 2022 Show and Conference in Detroit, leading experts in artificial intelligence (AI) will discuss how to put AI to use in manufacturing facilities in the keynote panel, "AI & Manufacturing - How Artificial Intelligence is Powering the Next Wave of Manufacturing." Technologists from Accenture, NVIDIA, General Motors, Landing AI and Intel will offer insights and best practices on how businesses can take advantage of AI to enhance their automation processes and improve efficiencies and productivity overall. "These experts will help companies better understand the intricate relationship between robots, automation, and artificial intelligence so decision makers can take advantage of the opportunities presented by smart technologies," said Jeff Burnstein, president of the Association for Advancing Automation, the organizer of the event. "The synergies among AI and automation technologies are powering the next wave of manufacturing, and we want everyone to feel empowered with this knowledge to move forward after Automate." Registration Still Open for Automate 2022 Automate, North America's leading automation trade show and conference, returns to Detroit next week after two decades in Chicago.

SAN DIEGO--(BUSINESS WIRE)-- Clearspeed, a leader in AI voice analytics, announced that the company has joined the Guidewire Insurtech Vanguards program, a new initiative led by property and casualty (P&C) cloud platform provider Guidewire (NYSE: GWRE), to help insurers learn about the newest insurtechs and how to best work with them. Through its exceptionally high level of fraud detection accuracy ( 97%), Clearspeed helps carriers decide quickly and confidently whether claims should go straight through or be flagged for further follow up. "We are honored to be showcased as an Insurtech Vanguard by Guidewire," says Clearspeed CEO, Alex Martin. "Clearspeed's easy integration with a carrier's existing tools and processes could enable Guidewire's 450 insurance customers to optimize their claims service while significantly improving their combined ratios." Insurtech Vanguards is a community of select startups and technology providers that are bringing novel solutions to the P&C industry.

Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces that the China National Medical Products Administration (NMPA) has cleared the company's investigational new drug application (IND) for AC0682 for the treatment of patients with estrogen receptor (ER)-positive breast cancers. AC0682 is an orally bioavailable chimeric degrader molecule designed to target ERα protein with high potency and selectivity. "Breast cancer is the most common cancer among women in China. We are excited about the IND clearance of AC0682 in China, after its IND clearance and initiation of a Phase 1 study in the US late last year," said Jie Fan, Ph.D., Chief Executive Officer, Accutar Biotechnology, Inc. "We look forward to accelerating the development of AC0682 and furthering our commitment to bringing innovative medicines to patients worldwide." The Phase 1 study in China will assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of AC0682 treatment in Chinese patients with ER-positive breast cancer.

Arnav Bawa, a student in the artificial intelligence program at Chandler Gilbert Community College, has developed an AI application to interpret EEG brain wave scans. The application can help predict brain seizures, so a patient can take medication or prevent injury from falling. William Glover, a student in the artificial intelligence program at Chandler Gilbert Community College, has developed an AI application for drones. The application can be used in indoor search and rescue situations. It uses AI to interpret a live video feed to look for and recognize people who may be trapped in a burning building.

The Business Intelligence Group today announced that Evisort is a winner in its inaugural Artificial Intelligence Excellence Awards program. Evisort is the leading provider of artificial intelligence (AI) solutions for contract management and analytics. This press release features multimedia. Evisort is a winner in The Business Intelligence Group's inaugural Artificial Intelligence Excellence Awards program. Evisort is the leading provider of artificial intelligence (AI) solutions for contract management and analytics.